Same Indication

Pembrolizumab vs Telmisartan

Pembrolizumab vs Telmisartan: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Telmisartan.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Telmisartan: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

Pharmacokinetics

Half-life: Pembrolizumab β€” 26 days; Telmisartan β€” 24 hours.

Chemical Properties

Molecular Formula: Telmisartan β€” C33H30N4O2.

Molecular Weight: Telmisartan β€” 514.6230 g/mol.

Type: Pembrolizumab β€” Antibody; Telmisartan β€” Small molecule.